ECADDCP 2018 by Expert Medical Events

Emerging Concepts in Anticancer Drug Development and Clinical Pharmacology (ECADDCP) 2018 is organized by Expert Medical Events and will be held during Nov 07 - 08, 2018 at Amsterdam, Noord Holland, Netherlands. The target audience for this medical event is Oncologists and clinical pharmacologists, particularly those in industry.

Course Description:
The complex landscape of oncology drug development is moving away from traditional dosing based on toxicity. As conventional strategies are becoming obsolete, it is vital for industry professionals to keep abreast of the novel approaches and modern tools that are becoming available in the development of anticancer drugs.

Developed by the award-winning and an honorary fellow of the American College of Clinical Pharmacology Mark J. Ratain, MD, this advanced course will focus on new directions in drug development strategies and will include discussion of drug combinations, immunotherapy, and oral dosing regimens. Mathematical approaches will be introduced, including studies on pharmacodynamic biomarkers and pharmacometric modeling of efficacy and toxicity.

This ambitious program will be delivered by the top oncology experts and thought leaders in an intimate and flexible setting, with generous time allocated to audience participation and availability of confidential sessions for company groups. A limited enrolment policy will also be put in place and will provide optimal networking opportunities and direct dialogue in a relaxed, informal, yet highly productive setting. This is a unique opportunity for oncologists and clinical pharmacologists involved in early clinical trials to optimize their professional performance and practice in an ever-changing and antagonistic landscape.

Conference Objectives are :
• To educate oncologists and clinical pharmacologists, particularly those working in an industry, regarding emerging concepts in anticancer drug development and clinical pharmacology
• To provide an opportunity for course participants to consult confidentially with thought leaders in oncology drug development and clinical pharmacology
• To facilitate networking among course participants and with thought leaders in the field
• To define appropriate strategies for identification of the optimal therapeutic dose (and/or schedule) of a drug alone, or in combination with other drugs
• To identify appropriate tools, such as biomarkers, pharmacometrics, and simulation, to address common problems in oncology drug development
• To interpret clinical pharmacokinetic and pharmacodynamic results in the context of preclinical drug metabolism and pharmacokinetic data

Additional details will be posted as soon as they are available.